Surprisingly, the major tumor suppressor pathways implicated in PDAC—p53, CDKN2A, and SMAD4—are not broadly engaged across the premalignant epithelium, but instead converge on a discrete progenitor-like population that displays high KRAS signaling and is transcriptionally poised for transformation. The gene discussed is TP53; the disease is neoplasm.